The Complement Laboratory is equipped with state-of-the-art immunoturbidimetric and ELISA platforms and adheres to CAP and NABL accreditation standards
HER2-mutant NSCLC typically has a poor prognosis and limited treatment options
_256_384.png)
Over 700 exhibitors from APAC, Europe, the US, and beyond showcased the latest in personal care innovation
Building a transparent, data-driven supply chain and self-reliant API ecosystem remains critical to reducing import dependence
Building on the Merck Foundation’s longstanding commitment to advancing access to high-quality health care, new national initiative supports grants to 11 organizations across the country
The upcoming state-of-the art 400+ bed facility is set to come up at an approximate cost of Rs 500 crore
Approval based on pivotal KOMET Phase III trial demonstrating significant tumour reduction in adults with NF1
Allergan Aesthetics reaffirms commitment to empowering girls through STEM mentorship and education initiatives
The antibody was designed and developed at Abzena’s Cambridge, UK,
Telangana aims to increase the value of the Life Sciences economy from US$ 80 billion to US$ 250 billion by 2030
Subscribe To Our Newsletter & Stay Updated
